Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical breast cancer"
DOI: 10.1016/j.clbc.2020.06.004
Abstract: INTRODUCTION Adherence to oral endocrine therapy (OET) reduces recurrence risk for hormone receptor (HR)-positive breast cancer (BC). Refill data accessed through electronic health records may provide objective assessment of OET adherence. Our goal was to… read more here.
Keywords: endocrine therapy; time therapy; breast cancer; therapy ... See more keywords
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2021 at "ERJ Open Research"
DOI: 10.1183/23120541.00778-2020
Abstract: Asthma is a chronic inflammatory condition that affects 3.8 million Canadians and nearly 65 000 acute asthma exacerbations occur each year [1–4]. Left untreated, asthma can lead to increasing mortality and morbidity [2, 5, 6]. Economically, the… read more here.
Keywords: therapy concomitant; use; concomitant medication; canada ... See more keywords